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Abstract
Background: The medical care chain around Down syndrome (DS) is complex, with many multidisciplinary
challenges. The current quality of care is unknown. Outcome-oriented quality indicators have the potential to
improve medical practice and evaluate whether innovations are successful. This is particularly interesting for the
evolving care for people with DS and intellectual disabilities (ID). The aim of this study was to identify existing
indicators for medical DS care, by reviewing the literature.
Methods: We systematically searched six databases (PubMed, EMBASE, Web of Science, CINAHL, PsycINFO, Google
Scholar) for studies concerning the development and implementation of quality indicators for DS and/or ID care,
published until February 1st 2015. The scoping review method was used, including systematic data extraction and
stakeholder consultation.
Results: We identified 13 studies concerning quality indicators for ID care that obtained data originating from
questionnaires (patient/family/staff), medical files and/or national databases. We did not find any indicator sets
specifically for DS care. Consulted stakeholders did not come up with additional indicator sets. Existing indicators
for ID care predominantly focus on support services. Indicators in care for people with ID targeting medical care are
scarce. Of the 70 indicators within the 13 indicator sets, 10% are structure indicators, 34% process, 32% outcome
and 24% mixed. Ten of the 13 sets include indicators on the WHO quality dimensions ‘patient-centeredness’,
‘effectiveness’ and ‘efficiency’ of care. ‘Accessibility’ is covered by nine sets, ‘equitability’ by six, and ‘safety’ by four.
Most studies developed indicators in a multidisciplinary manner in a joint effort with all relevant stakeholders; some
used focus groups to include people with ID.
Conclusion: To our knowledge, this is the first review that searched for studies on quality indicators in DS care.
Hence, the study contributes to existing knowledge on DS care as well as on measuring quality of care. Future
research should address the development of a compact set of quality indicators for the DS care chain as a whole.
Indicators should preferably be patient-centred and outcome-oriented, including user perspectives, while developed in
a multidisciplinary way to achieve successful implementation.
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Background
Down syndrome (DS), or (partial) trisomy 21, is the most
prevalent chromosomal anomaly among new-borns with
intellectual disabilities. The overall prevalence throughout
the world is about 10 per 10000 new-borns [1–3]. DS is
associated with a broad variety of age-related medical
problems, ranging from congenital heart disease to de-
mentia to recurrent respiratory infections [1–3]. The
care chain around a person with DS is challenging and
complex, involving numerous professionals [3–5]. This
requires coordination of care and adequate age- and
service-related transitions [4, 5].
Initiatives arise to improve the DS care. Skotko et al.
(2013) describe how a DS specialty clinic can identify
and address many healthcare needs of children and ad-
olescents with DS beyond the provision of primary care
[6]. In the Netherlands, numerous paediatric outpatient
clinics now organise such multidisciplinary team
appointments, including a visit to the paediatrician,
physiotherapist, ENT (earn-nose-throat)-specialist and
others, all on the same day. For adults with DS in the
Netherlands, healthcare is less organised, although some
18+ teams are being set up [7]. Internationally, difficulties
are identified in care transition (from paediatric to adult
care) and in persistent use of paediatric care by DS adults
[8]. An achievement towards higher quality care for DS
has been the development of guidelines [9, 10]. In general,
health checks are increasingly developed in the care for
people with intellectual disabilities (ID) [11, 12]. How-
ever, the quality of existing initiatives and the extent
to which healthcare professionals adhere to existing
guidelines is unclear [13, 14]. More insight is needed
into the care that is delivered to people with DS, in
terms of types of care, its quality and its effect on
clinical outcomes [14]. Quality indicators (also known
as quality measures [15, 16]) can provide this insight.
They have the potential to structure the development
of multidisciplinary teams, improve clinical decisions
and guide organisational reform [17]. This study aimed
to review existing data on quality indicators for DS
care, including both clinical and organisational aspects,
and to identify existing indicator sets.
Evaluating quality of healthcare (by using indicators)
starts with defining ‘quality of healthcare’. About half a
century ago (1966) Donabedian formulated the frequently
used framework that distinguishes three healthcare com-
ponents: structure, process and outcome [17]. Accordingly,
the quality of each of these ‘care components’ can be mea-
sured by structure, process or outcome indicators. Struc-
ture indicators assess the availability of the right facilities,
such as staff, supplies, policies and protocols, but also the
financial basis, e.g. insurance [18]. Process indicators as-
sess whether “good” medical care, according to current
evidence/knowledge, has been applied [17]. Care processes
are actions that take place between a patient and care pro-
vider, i.e. technical interventions (e.g. measuring blood
pressure) or interpersonal interactions (e.g. doctor-patient
communication) [19]. In practice, process indicators are
often operationalized as adherence to guidelines, but they
could also include general assumptions like access to and
timeliness of services, and coordination and continuation
of care. Outcomes are the consequences of delivered care
and the actual results of healthcare interventions, also
expressed as the five Ds: death, disease, discomfort,
disability and dissatisfaction [20]. Contributions of
healthcare to the patient’s quality and length of life
may also be qualified as outcomes of healthcare [21,
22]. Outcome indicators have the potential to evaluate
care cycles as a whole instead of single processes by
itself [23]. Traditionally, measurement instruments (such
as indicator sets) for quality of healthcare contain all three
types of indicators [24].
Next to these three types of healthcare components,
several quality dimensions of healthcare are defined. The
World Health Organisation (2006) defines six dimensions
of quality of care, i.e. care being effective, efficient, access-
ible, patient-centred, equitable and safe [25]. When it
comes to integrated care, other quality dimensions should
be considered as well, such as continuity and adequate
transitions between care organisations [26].
Additionally, quality of care can be assessed at differ-
ent levels, e.g. at the level of single providers, depart-
ments, hospitals or at the level of care chains as a whole:
the combined efforts of all care providers together [27].
In the end, it is this care chain that delivers the total
package of care to the patient, resulting in the final out-
come [23]. Addressing the care chain as a whole in qual-
ity evaluation is quite challenging, because so many
organisations and people are involved [23].
In order to contribute to quality improvement, indicators
measuring quality of healthcare should themselves be of
good quality, e.g. evidence based, and they should measure
what they are designed to measure. An instrument that
can be used as a manual to develop indicators is the AIRE
instrument (Appraisal of Indicators through Research and
Evaluation) [27]. In addition, AIRE can be used as a check-
list to appraise the quality of indicators [28].
This study aims to review existing quality indicators
for the DS care chain (for both children and adults with
DS). We focus on the following research question:
Which indicators are available to assess the clinical
and organisational quality of medical DS healthcare?
More specifically:
1) Which indicator sets are available and which
indicators do they contain?
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a. Which components and levels of care are covered
by these indicators?
b. Of which type (structure, process or outcome) are
these indicators?
2) What is the quality of these indicator sets?
a. Which dimensions of quality are covered by the sets?
b. How have the sets been developed and
implemented?
c. What can be said about other quality aspects of
the sets?
Methods
A scoping study was carried out to map available indicator
sets of healthcare for people with DS. A scoping study (or
scoping review) is a specific type of literature review that
may be used to examine research activity in a certain field
of study, assess the usefulness of conducting a full system-
atic review, summarise research findings, or identify gaps in
literature [29, 30]. Scoping studies are often conducted
when little research has been done on the topic studied and
a specific research question cannot be formulated [30, 31].
In an attempt to ascertain rigorousness and transparency,
Arksey and O’Mally (2005) constructed a framework for
conducting scoping studies [29]. The framework consists of
five stages: 1) identifying the research question; 2) identify-
ing relevant studies (search strategy); 3) selecting the stud-
ies; 4) charting the data (data extraction); 5) collating,
summarising and reporting the results; and 6) (optional)
consultation of stakeholders, resulting in suggestions for
additional references and views [29, 30]. We followed these
stages.
Search strategy
The databases of PubMed, EMBASE, Web of Science,
CINAHL, PsycINFO and Google Scholar were systematic-
ally searched for articles published until February 1, 2015
(no starting date). These six databases were selected to-
gether with a librarian to cover a wide range of biomedical
and psychological literature from the perspective of differ-
ent healthcare professionals (physicians, psychologists and
nurses). The first group of search terms consisted of syno-
nyms for people with DS. The second group of search
terms comprised outcomes to target quality indicators, in-
cluding quality management, quality improvement and
benchmarking. Since results for only DS(−synonyms) were
very scarce, the first group of search terms was broadened
by adding search terms for (synonyms for) people with in-
tellectual disabilities (ID) (Table 1). Search strategies were
similar for each database, except for Google Scholar,
which required a more narrowly defined search, since the
entry fields did not accept as many search terms as the
entry fields of the other databases.
Study selection
Figure 1 shows the selection process in a flowchart. Spe-
cific inclusion and exclusion criteria are listed in Table 2.
In the first selection phase, duplicates were removed,
and two independent reviewers (MH or FDM, and EV)
screened all titles. Titles were included in the next se-
lection phase when they concerned quality aspects of
healthcare for chronic conditions (comparable to DS care).
This review focuses on the care chain for individuals with
DS (or ID) from birth to end-of-life. Therefore, we ex-
cluded articles concerning prenatal screening. In the next
selection phase, abstracts were screened based on more
narrow criteria: focus on the development, implementa-
tion, application or evaluation of indicators for measuring
quality of healthcare. MH and FDM selected all abstracts
(partly by MH, partly by FDM) and a random selection of
30% of all abstracts was screened by a second reviewer
(EV, DD, AC, each 10%), which resulted in 26% differences
in interpretation. For instance, one abstract mentioned
‘Quality deficiencies’; FDM concluded from this that the
study was not about indicators, whereas DD thought qual-
ity deficiencies could be another word for quality indica-
tors: the study was selected. Another study was not
selected, because AC doubted about inclusion and FDM
interpreted that the study was not about indicators for
healthcare. Discussion between the reviewers resolved all
differences, which resulted in 100% agreement about in-
or exclusion. MH and FDM reviewed full texts (partly by
MH, partly by FDM). In case of any doubt, EV also
reviewed the articles and a third and fourth reviewer (DD
and AC) was consulted in case of disagreement. In this
final phase, quality indicators had to be the main topic,
well defined (as well as the population they applied to)
and more specifically concerning medical healthcare, as
opposed to e.g. residential care. A snowball method was
Table 1 Search strategy
Population: Outcomes:
1 Intellectual Disability
2 Mentally Disabled Persons
3 Developmental Disabilities
4 Down Syndrome
5 Developmental disorder*
6 Mental deficien*
7 Mental retard*
8 Down’s syndrome
9 Trisomy 21
10 (1 OR 2 OR 3 OR 4 OR 5
OR 6 OR 7 OR 8 OR 9)
(Google Scholar: 1 OR 2
OR 3 OR 4 OR 5 OR 6 OR 7)
19 (NOT) Pregnancy
11 Quality Indicators, Health Care
12 Quality Improvement
13 Total Quality Management
14 Benchmarking
15 Clinical indicator*
16 Quality measure*
17 Quality assessment*
18 (11 OR 12 OR 13 OR 14 OR 15
OR 16 OR 17) (Google Scholar:
11 OR 16)
Combining search term groups: 10 AND 18 NOT 19
This strategy is related to the PubMed search. Very similar versions were used
to search EMBASE, Web of Science, CINAHL, PsycINFO and Google Scholar, but
adapted for the specific search terms used in these databases, if available. The
search terms printed in italics are not MeSH-terms. All MeSH Terms were also
searched as free text in all databases as title/abstract
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Fig. 1 Flow chart of selection process. Number of studies found per database, title selection, abstract selection, full text selection, and snowball
method resulting in final inclusion of 13 studies
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applied in order to find additional studies: Reference lists
of the selected studies were screened for additional
relevant studies. If titles mentioned in the reference
lists suggested relevant information (on development,
implementation or evaluation of indicators), these stud-
ies were retrieved and, based on full texts, FDM
assessed whether the studies provided additional infor-
mation. If the studies provided information about add-
itional indicator sets and matched inclusion criteria,
these studies were included. If snowball-studies in turn
mentioned additional indicator sets in the text, corre-
sponding references were searched too and included if
relevant (this happened once).
Data extraction
As the included studies did not always provide enough
information to be able to answer our research questions,
additional information about the indicator sets was
sought. This was done by looking on websites of the
organisations who developed the indicator sets and by
entering the name of the indicator set in Google and
Google scholar.
We extracted data concerning general information
about the indicator sets (name of indicator set, author,
year, country, target population and organisational con-
text) and about quality domains covered. With the add-
itional information, we were able to assess the indicators
in the sets in terms of type (structure, process, or out-
come) and quality using the AIRE instrument (men-
tioned previously). Two researchers (FDM plus EV, DD
or AC) appraised each indicator set. The AIRE instru-
ment results in a score for each of its four categories: 1)
Aim, relevance and organisational context; 2) Involvement
of stakeholders; 3) Scientific evidence; and 4) Further
underpinning, formulation and use. For each category,
the reviewers need to score several items on a 4-point
Likert-scale: 1 meaning not at all agree and 4 meaning
very much agree. If no information was available about
an item, this was scored as 1. Table 3 provides an over-
view of the four categories of the instrument and of the
items per category.
One researcher (FDM) assessed the type of the indica-
tors, as the definition of the types was clear and all indi-
cators could be easily attributed to one of the three
types. Some indicators were very broadly defined and
were therefore classified as ‘mixed’, covering information
about two or more of the types. For each set, the per-
centages of the indicator types were calculated, after
which the percentages per type were added up in order
to provide an idea of relative distribution of indicator
types for all the indicators in the sets.
Consultation exercise
Twenty representatives from the healthcare perspective
(professionals providing different sorts of healthcare to
people with DS in the Netherlands) and three from the
healthcare receivers (board members of a leading Down
syndrome association in the Netherlands) were asked
(by e-mail) to review the list of selected studies and
check whether they missed studies or indicator sets. We
Table 2 Inclusion and exclusion criteria
Inclusion criteria:
• Studies concerning the development, implementation, application or
evaluation of (structure, process or outcome) indicators for measuring
quality of (chronic) medical healthcare for people with Down
syndrome or intellectual disabilities as the main topic
• Studies where specific quality indicators are well-defined including the
population they apply to
• All kinds of scientific publications: journal articles, theses, books, etc.
Exclusion criteria:
• Studies where quality indicators itself are not the main topic
• Studies not concerning medical care, but other forms of care (e.g.
residential care)
• Studies concerning general aspects of quality indicators (specific
indicators are not well-defined)
• Studies concerning quality indicators of general healthcare (specific
population is not described)
• Studies primarily focusing on the development of a tool, instrument or
questionnaire without the purpose of being an indicator for measuring
quality of healthcare
• Studies concerning prenatal or new-born screening/care
• No abstract/full text available
• Written in a language that no one in the research team masters (i.e.
not English, Dutch, French, German)
Table 3 AIRE instrument categories and items per category [27]
Categories Items
1) Aim, relevance and
organisational context
- Aim is clearly defined,
- Topic relevance is specified,
- Organisational configuration (level) is
specified,
- Quality domain is specified,
- Type and size of care process the indicator
set applies to is defined.
2) Involvement of
stakeholders
- Relevant healthcare professionals are
involved in developing the set,
- Relevant other are involved,
- The indicator set is formally established
(or owned), e.g. by a patient or professional
association.
3) Scientific evidence - Underpinning evidence for the set is
systematically searched,
- The set is based on a guideline,
- The Used evidence is qualitatively good.
4) Further underpinning,
formulation and use
- Denominator and numerator are clearly
described,
- Target population is specifically and clearly
defined,
- A risk adjustment strategy (for different
patient groups) is present,
- Validity of the set is proven or argued,
- Reliability of the set is proven or argued,
- Power of the set is proven or argued,
- The set is tested in practice,
- The effort needed for data collection is
taken into account,
- The set includes an instruction for
interpretation of the results.
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also asked them about their opinions concerning indicator
sets for DS care in general. Four representatives (from the
professionals group) did not review the identified studies
and indicator sets because of time constraints and/or lack
of interest in the topic.
Results
The literature search yielded 1184 studies (see Fig. 1).
No studies specific for DS care were found. Thirteen
studies were selected for final inclusion: they contained
quality indicators for medical healthcare in people with
ID (see Table 5, second column). Consultation of stake-
holders did not result in additional studies or indicator
sets. All stakeholders agreed that developing indicators
for medical care for people with DS would be worthwhile
for improving quality or transparency (see Table 4).
Research question 1: Which indicator sets are available
and which indicators do they contain?
Thirteen different indicator sets were identified (Table 5),
five of which originate from the UK, four from the USA,
one from Canada, one from Ireland, one from Sweden,
and one as a result of a partnership between 13 European
countries.
Out of the 13 identified indicator sets, three have not
been specifically developed for people with ID. The three
studies describing these sets only evaluated existing indi-
cators in people with ID, by comparison with the general
population (no. 9, Quality indicators for preventive care;
no. 3, Healthcare Effectiveness Data and Information
Set; no. 10, Quality care indicators of diabetes for people
with ID). Others adjusted existing sets of indicators to
apply them in care for people with ID (no. 1, Ambulatory
Care Sensitive Conditions; no. 2, Hospital Admissions for
Ambulatory Care Sensitive Conditions; no.5, Measure-
ment of Processes of Care; no. 11, Six Core Outcomes).
Three indicator sets have been developed or used for chil-
dren with, or at risk for, ID, i.e. no. 5 (MPOC-28), no. 9
(Quality indicators for preventive care), and no. 11 (Six
core outcomes). An overview of the indicators per set, in-
cluding their content, can be found as Additional file 1 to
this article.
Research question 1a: Which components and levels of
care are covered by the indicators?
The indicator sets cover a large variety of healthcare
levels (settings) and topics. The sets predominantly
evaluate the presence of facilities/services or the effectu-
ation of care delivery at communicational and organisa-
tional levels. Most of the sets include indicators on
collaboration, multidisciplinary cooperation, transition
and coordination. Five of the identified sets focus on
quality of supportive care and services, containing only a
subcategory of indicators being applicable to medical
care: no. 3 (The Health Equalities Framework, HEF), no.
6 (National Core Indicators, NCI), no. 7 (the NHS qual-
ity indicators for Learning Disabilities, NHS-QIS), no. 9
(the Quality indicators for preventive care), and no. 11
(the Six Core Outcomes). Medical care is approached in
a general way and specific diseases and/or treatment
courses are barely addressed. Indicators on medical
topics primarily focus on screening and preventive care.
Two sets consider hospitalisation rates as indicators for
conditions which, given effective primary care, should
not normally result in hospital admission. Their indicators
aim to measure access to, and quality of, primary care: no.
1 (Ambulatory Care Sensitive Conditions) and no. 2
(Hospital Admissions for Ambulatory Care Sensitive
Conditions). One set, no. 12 (Quality Outcomes Frame-
work, QOF) contains - among others - an indicator
named ‘Learning disabilities’, which comprises a meas-
ure for a register of patients with learning disabilities
and a measure for thyroid disease among people with
DS. This is the only set explicitly addressing DS. The
QOF indicators have been designed to measure the
quality of primary care in Great Britain. Two indicator
sets include measures for diabetes care for people with
intellectual disabilities (no. 3, Healthcare Effectiveness
Data and Information Set; no. 10, Quality care indicators
of diabetes for people with ID). Lastly, two sets focus on
processes of care: i.e. no. 5 (MPOC-28) concerning pro-
cesses in child rehabilitation and no. 13 (Quality indicators
for medication use process) including indicators for medi-
cation use in people with ID.
Research question 1b: Of which type (structure, process
and outcome) are the indicators?
The number of indicators per set varies widely. The thir-
teen sets together comprise 70 separate indicators, ran-
ging from 2 to 6 indicators per set. Most indicators in
turn consist of a number of sub-indicators ranging from
14 to 94. Altogether (regardless of sub-indicators) we
identified 6 structure, 21 process, 26 outcome indicators,
Table 4 Answers of stakeholders
Number of times mentioned
by stakeholders (N = 19)
Why are indicators for DS relevant?
To define care 8
For coordination 7
For quality improvement 8
For comparability of care providers 14
To check availability 3
Additional studies?
No 11
Yes but not about indicators 8
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and 12 indicators measuring a mix of structure-,
process-, or outcome-measures. When calculating the
percentages of types of indicators per sets, and then add-
ing up the percentages per type, it appeared that 10% of
the 70 indicators are structure indicators, 34% process,
32% outcome and 24% mixed. Table 6 presents the dis-
tribution of the types of indicators per set.
Research question 2: What is the quality of the indicator
sets?
The quality of the indicator sets was assessed using the
AIRE instrument. The AIRE-scores are presented in
Fig. 2.
Although category 1 did not get the highest score in
all sets (sets 1, 7, 8, 9, and 11 got a higher score on cat-
egory 2 and set 5 on category 3), category 1 is the best
scoring category on average. All sets have clearly defined
the aim and relevance and specify the organisational
configuration, type of care, quality dimension on which
the indicators apply, and indicate the relevance of the
topic. All WHO quality dimensions (effective, efficient,
accessible, patient-centred, equitable and safe) are covered
(Table 7), although some dimensions are only covered by
a small number of sets (e.g. only four indicator sets cover
‘safety’). The domains ‘effective’, ‘efficient’, and ‘patient-
centred’ are covered by ten of the sets. This implies that a
large part of the indicator sets aim to measure (and
improve) these dimensions of care. ‘Accessibility’ is
covered by nine sets, ‘equitability’ by six, and ‘safety’ by
four.
In general, there are differences in whether relevant
stakeholders have been involved in developing the sets
(AIRE-category 2). In most studies, indicators have been
developed in a multidisciplinary manner with involve-
ment of the relevant stakeholders. These stakeholders
involve general practitioners, paediatricians, psycholo-
gists, social workers, direct care staff, researchers, policy
makers, managers and/or family members. In most
cases, the actual content of the multidisciplinary team is
not clearly described. Two studies have been using focus
groups to include people with ID in the development
process (Atkinson et al. 2013, van Schrojenstein
Lantman-de Valk et al. 2007). Other ways of obtaining
data for the development of indicators include Delphi
studies, web-based applications, on-site observations,
staff questionnaires, medical file recordings, financial
registrations, content of protocols and/or national
databases.
The evidence base of the sets, category 3, provided the
lowest scores, though some sets score quite high (no. 1,
3, 4, 5 and 8).
Finally, category 4 (Further underpinning, formulation
and use) covers a large variety of indicator characteristics
(see Table 3) and the score for this category differs be-
tween the sets. Some of the sets do not contain indicators
with a numerator and denominator, e.g. the two sets on
diabetes care contain the indicator ‘patient’s HbA1c is
checked’. Furthermore, some sets clearly report how valid-
ity and reliability have been assured, while others do not
contain any information on that. The same is true for the
power of the sets (the extent to which an indicator is sens-
ible to measure changes). Almost all sets have to some ex-
tent been implemented and tested in practice. However,
some sets have only been implemented and tested once,
while others have been in use for many years. Data collec-
tion of the indicator sets also varied. For three of the sets,
data collection methods are not (yet) specified (sets 1, 4
and 13). Six of the sets (sets 5, 6, 8, 9, 10, and 11) collect
data through telephone surveys, postal questionnaires or
face-to-face interviews with people with ID or their repre-
sentatives. Three sets use existing registrations for obtain-
ing data (2, 3, and 7). For one set (12), general practices
have to score points on several topics, it is unclear
whether this is done through a questionnaire or existing
registrations.
Discussion
Summary of results
We reviewed the literature to identify indicators that as-
sess the clinical and organisational quality of medical
Table 6 Relative and absolute proportion of types of indicators
in identified indicator sets
Type of indicator→ Structure Process Outcome Mix
Indicator sets ↓
1 ACSC CAN 0 0 100% (15) 0
2 ACSC UK 0 0 100% (3) 0
3 HEDIS DM 0 100% (5) 0 0
4 HEF 0 40% (2) 20% (1) 40% (2)a
5 MPOC-28 0 100% (4) 0 0
6 NCI 20% (1) 20% (1) 20% (1) 40% (2)b
7 NHS-QIS 33% (2) 17% (1) 0 50% (3)c
8 POMONA 0 0 75% (3) 25% (1)d
9 Preventive care 0 75% (3) 25% (1) 0
10 Diabetes UK 0 0 0 100% (1)e
11 Six core outcomes 33% (2) 67% (4) 0 0
12 QOF 50% (1) 0 50% (1) 0
13 Medication use process 0 20% (1) 20% (1) 60% (3)f
Total 86 (6) 439 (21) 420 (26) 315 (12)
aMixed indicators consist of a mix of 1) structure & outcome sub-indicators
and 2) structure & process sub-indicators
bMixed indicators consist of a mix of 1) structure & process & outcome sub-
indicators and 2) structure & process sub-indicators
cMixed indicator consist of a mix of structure & process sub-indicators
dMixed indicator consist of a mix of structure & process sub-indicators
eMixed indicator consist of a mix of process & outcome sub-indicators
fMixed indicators consist of a mix of 1) process & outcome sub-indicators (2x)
and 2) process & outcome & structure sub-indicators
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care for people with DS. Only one of the found studies
described an indicator set containing one single indica-
tor on thyroid disease among people with DS; the other
studies were not about DS care. Therefore, we have
chosen to search for quality indicators in care for people
with ID that could be applicable in DS care. We have
found that quality indicators in care for people with ID
targeting medical care, instead of supportive care and
services, were scarce. We reviewed to what extent these
indicators cover the structure, process and outcome of
care. The majority of indicators concern processes of
care for performance measurement. Many sets include
Fig. 2 AIRE-scores per set. Scores are calculated as percentage of maximal achievable score. Each colour in a bar reflects the score for an
AIRE-score category
Table 7 Quality dimensions covered by indicator sets, per dimension
Quality dimension→ Effective Efficient Accessible Patient-centered Equitable Safe
Indicator sets ↓
1 ACSC CAN √ √ √
2 ACSC UK √ √ √
3 HEDIS DM √ √
4 HEF √ √ √ √ √
5 MPOC-28 √ √ √
6 NCI √ √ √ √
7 NHS-QIS √ √ √ √ √ √
8 POMONA √ √ √ √
9 Preventive care √ √ √ √
10 Diabetes UK √ √ √
11 Six core outcomes √ √ √ √
12 QOF √ √ √
13 Medication use process √ √ √ √ √
Number of sets covering dimension 10 10 9 10 6 4
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indicators on coordination, multidisciplinary working
and cooperation. The six WHO quality dimensions are
well covered by the sets, although ‘safety’ is the least ad-
dressed. We also aimed to evaluate the development and
implementation of the indicators. Most quality indica-
tors have been developed in a multidisciplinary manner
with relevant stakeholders, some using focus groups to
include people with ID. Almost all sets have to some ex-
tent been implemented and tested in practice. Data col-
lection for the indicators is achieved in multiple ways,
such as consumer/family surveys, medical file record-
ings, and/or national databases. The sets differ in quality
aspects, e.g. some authors describe thoroughly how val-
idity and reliability was assured, how sensible the indica-
tors are and what the evidence base is, while others
barely address these issues.
Quality indicators in medical care for people with ID and
DS
The most striking finding of the current study is that
quality indicators specific for DS care have not been
published to date (except for the single set containing
one indicator on thyroid disease among people with DS).
Moreover, the indicators found for the care for people
with ID barely address medical aspects. Generally, people
with DS and people with ID have similar health needs [4],
which may imply that the identified quality indicators
would be applicable in DS care as well. However, people
with DS usually have more and many specific comorbidi-
ties compared to the general population of people with ID
[4]. This urges the need for both medical care that is spe-
cifically tailored to the healthcare needs of people with DS
and DS specific indicators, which can contribute to the
quality of life of people with DS [6]. Indicators for care for
people with ID would not be specific enough. DS specific
indicators can reveal bottlenecks in the care chain and can
lead to the identification of successful interventions and
contributors to a specific outcome [23].
The high prevalence of comorbidities among people
with DS also requires multidisciplinary collaboration and
coordination. Many of the indicator sets found in this
study contain indicators for these requirements. They are
general concepts that are applicable to different healthcare
sectors, regardless of the patient group. Thus, regarding
multidisciplinary collaboration and coordination, the iden-
tified indicators could be used in a set for healthcare for
people with DS.
The six WHO quality dimensions could also be used
to define potential indicators [25]. In this study we found
that the dimensions ‘effective’, ‘efficient’, and ‘patient-
centred’ are predominantly covered (ten out of thirteen),
while improvement of care – addressing total care chains
– should always be done by paying attention to all the six
dimensions [25]. Nonetheless, we believe that ‘equitability’
and ‘patient-centeredness’ should receive special attention
in DS. People with DS experience inequality in received
healthcare [32]. The comorbidities, communication dif-
ficulties caused by intellectual disability, and unusual
presentation of common diseases of people with DS re-
quire more effort from healthcare professionals to de-
liver good care [6].
Structure, process or outcome of care
Of the indicator sets we found in this study, many consist
of a large number of process indicators. Outcome indica-
tors also comprise a significant part (although less than
process) of the indicators in the sets. The number of
structure indicators is the lowest.
Many organisations focus on the assessment of struc-
tural aspects and service delivery for performance meas-
urement. They seem to assess results that are easy to
reach and easy to measure, with data readily collectable
[19, 23, 33, 34]. Structural aspects of care are essential,
as they are the basis of the healthcare system. Structure
indicators are based on the assumption that given the
presence of right physical or staff characteristics, good
care automatically results [17]. However, focusing merely
on the structural context as an end in itself, may result
in overshadowing the initial goal of improving health
outcomes for patients [33].
Process indicators are based on how healthcare is deliv-
ered, e.g. coordination, timeliness, interactions, and what
interventions take place, e.g. screening or diagnostic tests,
treatment etc. Measuring processes has several benefits:
they can be measured on a short-term (i.e. directly after
care has been delivered), data are easily obtained and dif-
ferences between organisations are relatively easy to inter-
pret. In general, process indicators are largely based on
(the adherence to) guidelines, consisting of recommen-
dations based on current evidence, or best knowledge.
Measuring the adherence to guidelines results in im-
portant information on the feasibility of recommended
care and to some extent, information on care quality.
However, standards of best clinical practice are not
stable and almost never final [17]. When we solely
measure processes we might risk anchoring what is cur-
rently known as best practice, which might result in
ceasing of innovation [23].
Outcome indicators measure the consequences of deliv-
ered care and actual results of healthcare interventions.
They reflect whether structural context and processes in
single organisations, as well as total care chains [20], actu-
ally lead to health benefits. This information on desired,
as well as detrimental outcomes may stimulate innovation
through the identification of its contributing factors [23].
Outcomes can therefore be interpreted as fundamental
measures for quality of healthcare.
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Developing an indicator set for DS
According to the above, development of indicators for
medical care should focus on developing outcome indi-
cators. There are however some considerations that
should be taken into account. Firstly, stakeholders may
have different views on which outcomes are desirable.
Whereas survival may be the best scenario in the eyes of
a physician, a patient may choose functional status above
life expectancy. In addition, change in health-status may
not always be the primary goal, especially in long-term
care [26], support and processes of care may be of greater
importance. Indeed, when evaluating user perspectives on
this topic, users primarily seem to focus on processes of
care or procedural outputs [24, 26]. As patients are the ex-
perts when it comes to their outcomes, it is essential to in-
clude people with DS and/or their parents in the process
to define what is valuable to them [35]. Their views on
quality differ from those of professionals and researchers
[26]. Physicians and all other professionals, including
healthcare managers, should also be involved, since they
might appraise the usefulness and quality of indicators in
a different manner [36]. By involving all stakeholders in
the development process their conflicting interests can be
identified and weighed against each other. We also saw
this stakeholder involvement in the development of many
of the identified indicator sets. Defining potential quality
indicators for DS should thus involve all relevant stake-
holders [27, 37] (e.g. general practitioners, paediatricians,
psychologists, social workers, direct care staff, researchers,
policy makers, managers and family members).
Secondly, another consideration when developing out-
come indicators is that before outcomes become mani-
fest, long periods of time may elapse and data will not
be readily available [17, 19, 23]. Therefore, long-term
measures should be accompanied with intermediate,
short-term outcomes [20].
Thirdly, as stated before, multidisciplinary working is
of vital importance in medical care for people with DS.
Moreover, Callaghan (2006) argues that, especially for
people with ID, multidisciplinary collaboration leads to
better personal outcomes [38]. This would be a reason
for including process indicators, since multidisciplinary
working is a typical process aspect of care. On the other
hand, as multidisciplinary working leads to personal
outcomes, outcome indicators may also be suitable to
measure quality of care. In any case, multidisciplinary
collaboration should be taken into consideration, whether
it is measured by process or outcome indicators.
Fourthly, patient characteristics and environmental
factors, e.g. intrinsic motivation or socio-economic status,
have an important role in influencing health outcomes as
well, beyond the control of individual health professionals
[19], not to mention comorbidity. Hence, adjusting for
this kind of factors outside the healthcare system that may
influence health outcome is important when it comes
to interpreting outcomes data [20]. It has to be identi-
fied what exactly leads to the result that is measured.
Clinical expertise is needed for adequate interpretation,
though what the expected outcomes are, is not always
known [17].
Finally, when developing indicators one should con-
sider that healthcare systems differ per country or state
[19]. Indicators should fit in the care system they apply
to. In the Netherlands for example, some DS specific ini-
tiatives have been developed. However, specialised care
for adults with DS is still scarce [7]. Structural indicators
may help in the development of this care, by defining
what structural components of care are needed.
To conclude, quality indicators for medical DS care
should focus on outcomes, with the above consider-
ations advocating the additional use of some process and
structure indicators.
Strengths and limitations
To our knowledge, this is the first review that searched
for studies on quality indicators in DS care. With the
use of six different databases, we covered a wide range
of scientific publications. Moreover, this review discusses
strategies for future development of indicators. The study
contributes to existing knowledge on DS care as well as
on measuring quality of care for other chronic conditions.
A strength of the study is the consultation of relevant
stakeholders as a last step of the review, which enabled us
to check whether we had missed relevant studies or indi-
cator sets. The fact that no additional indicator sets or
studies came up in the stakeholder consultation, shows
that we did not miss studies and advocates the quality of
this review. Additionally, all stakeholders considered de-
velopment of quality indicators for care for people with
DS relevant, which also indicates the relevance of this
study.
This study yielded no indicator sets on medical DS
healthcare and the found indicator sets for ID healthcare
predominantly focus on non-medical care (e.g. supportive
care). This may be the result of including (synonyms for)
intellectual disabilities as a search term, which may have
put an emphasis on cognitive disability, which is not ne-
cessarily related to medical care. Using search terms on
for example congenital abnormality or genetic defects
might have possibly yielded more medical studies. How-
ever, these studies might have been too general and less
applicable to DS. As ID is one of the outcomes of DS, we
chose to search for studies on ID.
A limitation of the study was that the information of
the identified indicator sets was somewhat incomplete.
We only searched for information through the internet.
Due to this incomplete information, not all items of the
AIRE instrument, used to assess the quality, could be
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scored by the reviewers. Therefore, the low AIRE scores,
especially regarding the evidence base of the sets, do not
necessarily mean that the evidence base of the sets is
not good. The low scores may also be a result of little
available information on the sets. Consulting organisa-
tions that had developed the indicator sets might have
yielded more information. However, the number of items
with missing information is small and without the AIRE-
scores, we are still able to show information on quality
(development, implementation, quality domains).
Conclusions
This review gives an overview of different strategies for
quality measurement. Quality indicators specific for DS
care have not been published to date and in the found
studies about the care for people with ID medical as-
pects are barely addressed. Quality indicators can play a
major role in improving medical practice and evaluating
whether innovations are successful. This is particularly
interesting for the evolving DS care, as well as care for
people with ID. As illustrated in this review, it is very
hard to focus on specific care quality aspects, when ap-
proaching such a diverse, large group as ‘people with intel-
lectual disabilities’. Therefore, we recommend focussing
on well-defined, DS-specific care chains when developing
indicators. Further research activities should include the
preparation and development of a compact set of indica-
tors to evaluate and monitor the quality of the DS care
chain as a whole. Future indicators should preferably be
patient-centred and outcome-oriented, including user per-
spectives. In order to achieve successful implementation,
it is crucial that all care providers support the indicator
set, and that all care providers, patients (and/or their par-
ents), and healthcare managers are involved in the process
of development.
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